Navi Mumbai, March 10: Four candidates appearing for the ongoing Navi Mumbai police recruitment were detained after they were suspected of using steroid injections to enhance their performance during ...
Sequel Med Tech today announced the broad availability of its twiist automated insulin delivery system in the U.S.
Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.
Beta Bionics (NASDAQ:BBNX) executives used a conference presentation to outline the company’s strategy in insulin delivery, ...
MOUNJARO pens will be shrunk from April to try and stop patients squeezing out a “golden” fifth dose after the four prescribed shots. Users of the weight loss jab have for months been injecting ...
Children and adolescents with diabetes using inhaled insulin had an increase in HbA1c from baseline to 1 year, according to data from the INHALE-1 extension trial published in Diabetes Technology & ...
AUSTIN, TX / ACCESS Newswire / March 2, 2026 / In modern metabolic medicine, few treatments have reshaped care like GLP-1 receptor agonists. If you are asking what is semaglutide, it is a prescription ...
Growing numbers of people are injecting unregulated peptides for health reasons - but one expert says they are "lab rats".
Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art syringe for use with its NASHA® lidocaine range of Restylane ...
Kennedy Jr., secretary of the U.S. Department of Health and Human Services, who has vowed to end the FDA’s “aggressive ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...
Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky. After nearly two and a half decades of steadily increasing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results